Publications by the researcher in collaboration with SARA CARBAJO PESCADOR (13)

2019

  1. Beneficial effects of exercise on gut microbiota functionality and barrier integrity, and gut-liver crosstalk in an in vivo model of early obesity and non-alcoholic fatty liver disease

    DMM Disease Models and Mechanisms, Vol. 12, Núm. 5

2017

  1. Melatonin enhances sorafenib actions in human hepatocarcinoma cells by inhibiting mTORC1/p70S6K/HIF-1α and hypoxiamediated mitophagy

    Oncotarget, Vol. 8, Núm. 53, pp. 91402-91414

2015

  1. Understanding nutritional interventions and physical exercise in non-alcoholic fatty liver disease

    Current Molecular Medicine, Vol. 15, Núm. 1, pp. 3-26

2014

  1. FoxO proteins: Regulation and molecular targets in liver cancer

    Current Medicinal Chemistry, Vol. 21, Núm. 10, pp. 1231-1246

  2. Inhibition of matrix metalloproteinase-9 and nuclear factor kappa B contribute to melatonin prevention of motility and invasiveness in HepG2 liver cancer cells

    Journal of Pineal Research, Vol. 56, Núm. 1, pp. 20-30

  3. On-line surface plasmon resonance biosensing of vascular endothelial growth factor signaling in intact-human hepatoma cell lines

    Analyst, Vol. 139, Núm. 6, pp. 1426-1435

2013

  1. Inhibition of VEGF expression through blockade of Hif1α and STAT3 signalling mediates the anti-angiogenic effect of melatonin in HepG2 liver cancer cells

    British Journal of Cancer, Vol. 109, Núm. 1, pp. 83-91

  2. Melatonin induces transcriptional regulation of Bim by FoxO3a in HepG2 cells

    British Journal of Cancer, Vol. 108, Núm. 2, pp. 442-449

  3. New therapeutic approach: Diphenyl diselenide reduces mitochondrial dysfunction in acetaminophen-induced acute liver failure

    PLoS ONE, Vol. 8, Núm. 12

2012

  1. Investigación básica sobre hepatocarcinoma en la Universidad de León

    AmbioCiencias: revista de divulgación, Núm. 9, pp. 39-56

  2. Reduction of acute hepatic damage induced by acetaminophen after treatment with diphenyl diselenide in mice

    Toxicologic Pathology, Vol. 40, Núm. 4, pp. 605-613

2011

  1. Melatonin modulation of intracellular signaling pathways in hepatocarcinoma HepG2 cell line: Role of the MT1 receptor

    Journal of Pineal Research, Vol. 51, Núm. 4, pp. 463-471

2009

  1. Changes in the expression of melatonin receptors induced by melatonin treatment in hepatocarcinoma HepG2 cells

    Journal of Pineal Research, Vol. 47, Núm. 4, pp. 330-338